Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 1/2019

27.07.2018 | Original Paper

Mindfulness-Based Interventions for Adults Living with HIV/AIDS: A Systematic Review and Meta-analysis

verfasst von: Lori A. J. Scott-Sheldon, Brittany L. Balletto, Marissa L. Donahue, Melissa M. Feulner, Dean G. Cruess, Elena Salmoirago-Blotcher, Rena R. Wing, Michael P. Carey

Erschienen in: AIDS and Behavior | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

This meta-analysis examined the effects of mindfulness-based interventions (MBIs) on stress, psychological symptoms, and biomarkers of disease among people living with HIV/AIDS (PLWHA). Comprehensive searches identified 16 studies that met the inclusion criteria (N = 1059; M age = 42 years; 20% women). Participants had been living with HIV for an average of 8 years (range = < 1–20 years); 65% were currently on antiretroviral therapy. Between-group analyses indicated that depressive symptoms were reduced among participants receiving the MBIs compared to controls (d+ = 0.37, 95% CI 0.03, 0.71). Within-group analyses showed reductions in psychological symptoms (i.e., less anxiety, fewer depressive symptoms) and improved quality of life over time among MBI participants (d+s = 0.40–0.85). No significant changes were observed for immunological outcomes (i.e., CD4 counts) between- or within-groups. MBIs may be a promising approach for reducing psychological symptoms and improving quality of life among PLWHA. Studies using stronger designs (i.e., randomized controlled trials) with larger sample sizes and longer follow-ups are needed to clarify the potential benefits of MBIs for PLWHA.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Creswell et al. [54 used a brief version of MBSR as the comparison condition. Therefore, within-group analyses included this comparison condition as a MBI rather than a control. The pattern of results did not change when the brief MBSR condition was included as a control condition (data not shown).
 
2
Wood [49] assessed but did not report CD4 + counts at baseline.
 
Literatur
1.
2.
3.
Stanton AL, Revenson TA, Tennen H. Health psychology: psychological adjustment to chronic disease. Annu Rev Psychol. 2007;58:565–92.CrossRef
4.
Dougall AL, Baum A. Stress, health, and illness. In: Baum A, Revenson TA, Singer JE, editors. Handbook of health psychology. 2nd ed. New York, NY: Taylor & Francis; 2012. p. 53–78.
5.
Lopez JD, Shacham E, Brown T. Suicidal ideation persists among individuals engaged in HIV care in the era of antiretroviral therapy. AIDS Behav. 2017;22(3):500–8.
6.
Gay C, Portillo CJ, Kelly R, Coggins T, Davis H, Aouizerat BE, et al. Self-reported medication adherence and symptom experience in adults with HIV. J Assoc Nurses AIDS Care. 2011;22:257–68.CrossRef
7.
Wilson NL, Azuero A, Vance DE, Richman JS, Moneyham LD, Raper JL, et al. Identifying symptom patterns in people living with HIV disease. J Assoc Nurses AIDS Care. 2016;27(2):121–32.CrossRef
8.
9.
Kemeny ME, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun. 2007;21(8):1009–18.CrossRef
10.
McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338(3):171–9.CrossRef
11.
The Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–56.CrossRef
12.
Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, et al. Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals. AIDS. 2017;31(10):1471–81.CrossRef
13.
Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV. 2014;1:e32–40.CrossRef
14.
Campsmith ML, Nakashima AK, Davidson AJ. Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. Health Qual Life Outcomes. 2003;1:12.CrossRef
15.
Creswell JD. Mindfulness interventions. Annu Rev Psychol. 2017;68:491–516.CrossRef
16.
Kabat-Zinn J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain, and illness. New York: Delta; 1990.
17.
Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. New York: Guilford Press; 2012.
18.
Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosomat Res. 2010;68:539–44.CrossRef
19.
Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res. 2004;57(1):35–43.CrossRef
20.
Hilton L, Hempel S, Ewing BA, Apaydin E, Xenakis L, Newberry S, et al. Mindfulness meditation for chronic pain: systematic review and meta-analysis. Ann Behav Med. 2016;51(2):1–15.
21.
Antoni MH. Stress management and psychoneuroimmunology in HIV infection. CNS Spectr. 2003;8:40–51.CrossRef
22.
Creswell JD, Lindsay EK. How does mindfulness training affect health? A mindfulness stress buffering account. Curr Direct Psychol Sci. 2014;23:401–7.CrossRef
23.
Robinson FP, Mathews HL, Witek-Janusek L. Stress reduction and HIV disease: a review of intervention studies using a psychoneuroimmunology framework. J Assoc Nurses AIDS Care. 2000;11(2):87–96.CrossRef
24.
Scott-Sheldon LAJ, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 2008;27(2):129–39.CrossRef
25.
Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol. Rev. 2015;9:224–43.CrossRef
26.
Yang Y, Liu YH, Zhang HF, Liu JY. Effectiveness of mindfulness-based stress reduction and mindfulness-based cognitive therapies on people living with HIV: a systematic review and meta-analysis. Int J Nurs Sci. 2015;2:283–94.
27.
Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Nat Health Stat Rep. 2008;12:1–23.
28.
Moskowitz JT, Wrubel J, Hult JR, Maurer S, Acree M. Illness appraisals and depression in the first year after HIV diagnosis. PLoS ONE. 2013;8(10):e78904.CrossRef
29.
Johnson BT, Scott-Sheldon LA, Carey MP. Meta-synthesis of health behavior change meta-analyses. Am J Public Health. 2010;100(11):2193–8.CrossRef
30.
Van Daele T, Hermans D, Van Audenhove C, Van den Bergh O. Stress reduction through psychoeducation: a meta- analytic review. Health Educ Behav. 2012;39(4):474–85.CrossRef
31.
Moher D, Liberati A, Tetzlaff J, Altman DG. Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.CrossRef
32.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.CrossRef
33.
Miller WR, Brown JM, Simpson TL, Handmaker NS, Bien TH, Luckie LF. What works? A methodological analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR, editors. Handbook of alcohilsm treatment approaches: effective alternatives. Boston, MA: Allyn and Bacon; 2003. p. 12–44.
34.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health. 1998;52:377–84.CrossRef
35.
Miller WR, Brown JM, Simpson TL, Handmaker NS, Bien TH, Luckie LF. What works? A methodological analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR, editors. Handbook of alcoholism treatment approaches: effective alternatives. 2nd ed. Needham Heights, MA: Allyn & Bacon; 1995. p. 12–44.
36.
Fowkes FG, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ. 1991;302(6785):1136–40.CrossRef
37.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Erlbaum; 1998.
38.
Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7:105–25.CrossRef
39.
Sanchez-Meca J, Marin-Martinez F, Chacon-Moscoso S. Effect-size indices for dichotomized outcomes in meta-analysis. Psychol Methods. 2003;8(4):448–67.CrossRef
40.
Johnson BT, Eagly AH. Meta-Analysis of Research in Social and Personality Psychology. In: Reis HT, Judd CM, editors. Handbook of research methods in social and personality psychology. 2nd ed. London: Cambridge University Press; 2014. p. 675–707.
41.
Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA: Sage; 2001.
42.
Hedges LV. Distribution theory for Glass’s estimator of effect size and related estimators. J Educ Behav Stat. 1981;6:107–28.CrossRef
43.
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193–206.CrossRef
44.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef
45.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRef
46.
Hedges LV. Fixed effects models. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. p. 285–99.
47.
StataCorp. Stata/SE. 12.1 for Windows ed. College Station, TX: StataCorp LP; 2013.
48.
Wilson DB. Meta-analysis macros for SAS, SPSS, and Stata. 2001.
49.
Wood NA. Mindfulness-based cognitive therapy for the symptoms of depression in a community-based HIV/AIDS clinic: outcomes and feasibility (Dissertation). Ann Arbor: Widener University; 2009.
50.
Kelly PJ. (ed) Evaluation of a meditation and hypnosis-based stress management program for men with HIV. Fifth International Conference on AIDS; Montreal: 1989.
51.
Leaity S, Hennessey S, (eds). Outcomes of a pilot mindfulness-based cognitive therapy (MBCT) group for people with HIV. 2006 Division of Clinical Psychology Annual Conference; London; 2006.
52.
53.
Gayner B, Esplen M, DeRoche P, Wong J, Bishop S, Kavanagh L, et al. A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV. J Behav Med. 2012;35:272–85.CrossRef
54.
Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4 + T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23:184–8.CrossRef
55.
Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manag. 2012;43:161–71.CrossRef
56.
Moskowitz JT, Hult JR, Duncan LG, Cohn MA, Maurer S, Bussolari C, et al. A positive affect intervention for people experiencing health-related stress: development and non-randomized pilot test. J Health Psychol. 2012;17:676–92.CrossRef
57.
Friary V, Farag S. A prática de mindfulness (MBSR) como dispositivo terapêutico no tratamento da depressão em pacientes HIV-positivo: Resultados de um estudo-piloto [Outcomes of a pilot-group using mindfulness-based stress reduction (MBSR) for people living with HIV with mild-moderate depression]. Revista Saúde e Desenvolvimento Humano. 2013;1(2):17–35.
58.
George MC, Wongmek A, Kaku M, Nmashie A, Robinson-Papp J. A mixed-methods pilot study of mindfulness-based stress reduction for HIV-associated chronic pain. Behav Med. 2016;43:108–19.CrossRef
59.
SeyedAlinaghi S, Jam S, Foroughi M, Imani AH, Mohraz M, Djavid GE, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4 + T lymphocyte count and medical and psychological symptoms. Psychosom Med. 2012;74:620–7.CrossRef
60.
Baijesh AR. Mindfulness based cognitive therapy for depression among HIV-infected individuals. Int J Indian Psychol. 2015;3:103–10.
61.
Schadé A, van Grootheest G, Smit JH. Mindfulness Based Cognitive Therapy (MBCT) as an addition to psychiatric care as usual for HIV-infected patients with mental health symptoms. J AIDS Clin Res. 2016;7(2):547.CrossRef
62.
Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006;333(7568):597–600.CrossRef
63.
Roemer L, Orsillo SM. Mindfulness-and acceptance-based behavioral therapies in practice. New York: Guilford Press; 2010.
64.
Brown JL, Vanable PA. Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research. Neurobehav HIV Med. 2011;3:95–106.CrossRef
65.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.CrossRef
66.
Patterson S, Moran P, Epel E, Sinclair E, Kemeny ME, Deeks SG, et al. Cortisol patterns are associated with T cell activation in HIV. PLoS ONE. 2013;8:e63429.CrossRef
67.
Robinson FP, Mathews HL, Witek-Janusek L. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J Altern Complement Med. 2003;9(5):683–94.CrossRef
68.
Ironson GH, Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med. 2008;70(5):546.CrossRef
69.
Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011;203(4):442–51.CrossRef
70.
Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, et al. Do gender differences in CD4 cell counts matter? AIDS. 1999;13:2361–4.CrossRef
71.
Jam S, Imani AH, Foroughi M, SeyedAlinaghi S, Koochak HE, Mohraz M. The effects of mindfulness-based stress reduction (MBSR) program in Iranian HIV/AIDS patients: a pilot study. Acta Med Iran. 2010;48(2):101–6.PubMed
72.
Creswell JD. Biobehavioral effects of mindfulness-based stress reduction in HIV (Dissertation). Ann Arbor: University of California, Los Angeles; 2007.
73.
Gonzalez-Garcia M, Ferrer MJ, Borras X, Muñoz-Moreno JA, Miranda C, Puig J, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 2014;18(4):676–85.CrossRef
74.
Cohn MA, Epel ES, Moskowitz JT, Moran PP, Acree M, Folkman S, et al. High adherence enhances effects of mindfulness-based stress reduction. Psychosom Med. 2011;73:A63–4.
75.
Riddell RA. Mindfulness-based stress reduction, stress appraisal, and cardiovascular reactivity in HIV-positive men exposed to an acute laboratory stressor (Dissertation). Ann Arbor: The Wright Institute; 2014.
76.
Moskowitz JT, Duncan LG, Moran PJ, Acree M, Epel ES, Kemeny ME, et al. Dispositional mindfulness in people with HIV: associations with psychological and physical health. Personal Individ Differ. 2015;86:88–93.CrossRef
77.
78.
Robinson FP. Psycho-endocrine-immune response to mindfulness-based stress reduction in HIV-infected individuals (Dissertation). Chicaco, IL: Loyola University Chicago; 2002.
79.
Schadé A, van Grootheest G, Smit JH. HIV-infected mental health patients: characteristics and comparison with HIV-infected patients from the general population and non-infected mental health patients. BMC Psychiatr. 2013;13:35.CrossRef
Metadaten
Titel
Mindfulness-Based Interventions for Adults Living with HIV/AIDS: A Systematic Review and Meta-analysis
verfasst von
Lori A. J. Scott-Sheldon
Brittany L. Balletto
Marissa L. Donahue
Melissa M. Feulner
Dean G. Cruess
Elena Salmoirago-Blotcher
Rena R. Wing
Michael P. Carey
Publikationsdatum
27.07.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2236-9

Weitere Artikel der Ausgabe 1/2019

AIDS and Behavior 1/2019 Zur Ausgabe

Original Paper

Effects of a School-Based Intervention on Frequency and Quality of Adolescent-Parent/Caregiver Sexuality Communication: Results from a Randomized-Controlled Trial in Uganda

Original Paper

A Randomized Controlled Pilot Study of a Culturally-Tailored Counseling Intervention to Increase Uptake of HIV Pre-exposure Prophylaxis Among Young Black Men Who Have Sex with Men in Washington, DC

Original Paper

A Randomized Controlled Trial to Increase HIV Testing Demand Among Female Sex Workers in Kenya Through Announcing the Availability of HIV Self-testing Via Text Message

Original Paper

A Pilot Intervention Trial to Promote Sexual Health and Stress Management Among HIV-Infected Men Who Have Sex with Men

Original Paper

Does Quality of Life and Sexual Quality of Life in HIV Patients Differ Between Non-treated HIV Controllers and Treated Patients in the French ANRS VESPA 2 National Survey?

Original Paper

Estimating the Population Size of Males Who Inject Drugs in Myanmar: Methods for Obtaining Township and National Estimates

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise